Spotting Winners: Genesco (NYSE:GCO) And Footwear Stocks In Q1
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let's take a look at how footwear stocks fared in Q1, starting with Genesco (NYSE:GCO).
Before the advent of the internet, styles changed, but consumers mainly bought shoes by visiting local brick-and-mortar shoe, department, and specialty stores. Today, not only do styles change more frequently as fads travel through social media and the internet but consumers are also shifting the way they buy their goods, favoring omnichannel and e-commerce experiences. Some footwear companies have made concerted efforts to adapt while those who are slower to move may fall behind.
The 8 footwear stocks we track reported a strong Q1. As a group, revenues beat analysts' consensus estimates by 1.4% while next quarter's revenue guidance was in line.
Thankfully, share prices of the companies have been resilient as they are up 5.5% on average since the latest earnings results.
Spanning a broad range of styles, brands, and prices, Genesco (NYSE:GCO) sells footwear, apparel, and accessories through multiple brands and banners.
Genesco reported revenues of $474 million, up 3.6% year on year. This print exceeded analysts' expectations by 2.2%. Overall, it was a strong quarter for the company with an impressive beat of analysts' adjusted operating income estimates and full-year EPS guidance topping analysts' expectations.
Mimi E. Vaughn, Genesco's Board Chair, President and Chief Executive Officer, said, 'Following the significant momentum in last year's back half, we are pleased with our start to fiscal 2026 with both sales and profitability coming in above our expectations. Our first quarter performance was highlighted by our third consecutive quarter of positive comparable sales increases, with results once again driven by Journeys, as our strategic plan to accelerate growth and increase market share continues to gain traction. At the same time, the work we've done realigning our cost structure including our ongoing store optimization initiatives, helped drive a nice year-over-year improvement in operating income.'
The stock is up 1.5% since reporting and currently trades at $22.70.
Is now the time to buy Genesco? Access our full analysis of the earnings results here, it's free.
Originally selling Japanese Onitsuka Tiger sneakers as Blue Ribbon Sports, Nike (NYSE:NKE) is a global titan in athletic footwear, apparel, equipment, and accessories.
Nike reported revenues of $11.27 billion, down 9.3% year on year, outperforming analysts' expectations by 2.3%. The business had a stunning quarter with a solid beat of analysts' EPS estimates and an impressive beat of analysts' EBITDA estimates.
The market seems unhappy with the results as the stock is down 13.5% since reporting. It currently trades at $62.15.
Is now the time to buy Nike? Access our full analysis of the earnings results here, it's free.
The owner of Dr. Scholl's, Caleres (NYSE:CAL) is a footwear company offering a range of styles.
Caleres reported revenues of $614.2 million, down 6.8% year on year, falling short of analysts' expectations by 1.3%. It was a disappointing quarter as it posted a significant miss of analysts' adjusted operating income and EPS estimates.
Caleres delivered the weakest performance against analyst estimates in the group. As expected, the stock is down 16.4% since the results and currently trades at $13.70.
Read our full analysis of Caleres's results here.
Established in 1973, Deckers (NYSE:DECK) is a footwear and apparel conglomerate with a portfolio of lifestyle and performance brands.
Deckers reported revenues of $1.02 billion, up 6.5% year on year. This result beat analysts' expectations by 2.4%. Overall, it was a strong quarter as it also logged an impressive beat of analysts' constant currency revenue and EPS estimates.
The stock is down 12% since reporting and currently trades at $111.05.
Read our full, actionable report on Deckers here, it's free.
Founded in 1883, Wolverine Worldwide (NYSE:WWW) is a global footwear company with a diverse portfolio of brands including Merrell, Hush Puppies, and Saucony.
Wolverine Worldwide reported revenues of $412.3 million, up 4.4% year on year. This number surpassed analysts' expectations by 4.1%. It was a very strong quarter as it also put up an impressive beat of analysts' EPS estimates and a solid beat of analysts' adjusted operating income estimates.
Wolverine Worldwide scored the biggest analyst estimates beat among its peers. The stock is up 25.8% since reporting and currently trades at $18.63.
Read our full, actionable report on Wolverine Worldwide here, it's free.
Thanks to the Fed's series of rate hikes in 2022 and 2023, inflation has cooled significantly from its post-pandemic highs, drawing closer to the 2% goal. This disinflation has occurred without severely impacting economic growth, suggesting the success of a soft landing. The stock market thrived in 2024, spurred by recent rate cuts (0.5% in September and 0.25% in November), and a notable surge followed Donald Trump's presidential election win in November, propelling indices to historic highs. Nonetheless, the outlook for 2025 remains clouded by potential trade policy changes and corporate tax discussions, which could impact business confidence and growth. The path forward holds both optimism and caution as new policies take shape.
Want to invest in winners with rock-solid fundamentals? Check out our Strong Momentum Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Forbes
32 minutes ago
- Forbes
Japan's Largest Companies 2025: Rare Interest Rate Hikes Lead To A Volatile Year
Toyota and other Japanese automakers have been hampered by Trump's tariffs. Getty Images Japan's stock market has been on a roller-coaster ride over the past 12 months. Its benchmark Nikkei index reached an all-time high in July 2024, driven by corporate governance reforms and robust company earnings, then crashed more than 25% in less than four weeks on a surprise interest rate hike by the Bank of Japan. Though the index rebounded shortly after, its gains were trimmed in early 2025 as U.S. President Donald Trump ignited his trade war. Japan has 180 companies on this year's Forbes Global 2000 ranking of the world's largest public corporations, down slightly from 182 in 2024, making it the third most-represented country after the U.S. and China. The list weighs market value, revenue, profit and assets equally, using the latest 12 months of data as of April 25. Toyota Motor, the highest-ranking Japanese company, is in a sector particularly hard hit by Trump's sweeping tariffs. The U.S. in early April imposed a 25% tax on foreign-made cars, followed in early May by the same levy on auto parts, a blow to Japan's mainstay industry and its export-led economy. The world's top-selling carmaker slipped three places to No. 14 after its stock tumbled 22% over the year. Though its revenues and profits in the year through December were roughly flat at $309 billion and $34 billion, respectively, Toyota warned that the tariffs would result in a $1.3 billion hit to operating profit in April and May. Some of Toyota Motor's peers suffered even steeper declines. Nissan Motor, long plagued by deteriorating financials, sank 366 spots to No. 707 after its profit in the 12 months through December plunged 76% to $702.6 million. After the cut-off date for the list, the automaker posted a $4.7 billion loss for the three months ended March. Nissan is struggling to restructure after merger talks with larger rival Honda Motor collapsed in February. The failed tie-up, together with the tariffs, relegated Honda to No. 117 from No. 91 as its stock fell 17% over the year. Mitsubishi Motors, whose biggest shareholder is Nissan, tumbled 379 places to No. 1,562 as its shares skidded almost 10%. Companies in the AI space were a bright spot. Billionaire Masayoshi Son's SoftBank investment powerhouse climbed 331 spots to No. 130 on a 425% surge in 12-month profit through December to $5.6 billion, driven partly by increases in the value of portfolio companies such as ByteDance, the Chinese parent of TikTok. SoftBank is ramping up its AI bet, with plans to invest up to $30 billion in U.S.-based ChatGPT maker OpenAI while also investing $100 billion to build AI infrastructure stateside as part of its Stargate Project joint venture with OpenAI and Oracle. The AI boom also lifted Advantest, the world's largest semiconductor testing equipment maker by market share and a supplier to AI-chip giant Nvidia. It scaled 509 places to No. 1,231 as its profit in the year through March more than doubled to $1.1 billion on a 52% surge in sales to $5.1 billion. Other notable climbers included companies in the defense industry. IHI Corp, Mitsubishi Heavy Industries (MHI) and Kawasaki Heavy Industries (KHI) were among the best performers on the Nikkei over the year as Japan ramped up military spending. IHI, an engineering company that makes everything from turbines for power plants to rocket systems for space travel, debuted on the Global 2000 at No. 1,349 after its stock skyrocketed 176%. A more than doubling in MHI stock elevated the company 75 spots to No. 372 while KHI vaulted 513 places to No. 1,331 on a 52% share increase.
Yahoo
36 minutes ago
- Yahoo
Japan Baby Care Products Market Competition, Forecast & Opportunities Report 2025: Major Players in Japan's Baby Care Market Focus on Quality and Innovation
The Japan Baby Care Products Market is expanding, driven by higher per-child spending and a demand for sustainable, health-conscious products. Opportunities include leveraging e-commerce, catering to organic and culturally preferred ingredients, and aligning with government policies on nutrition and sustainability. Japanese Baby Care Products Market Dublin, June 12, 2025 (GLOBE NEWSWIRE) -- The "Japan Baby Care Products Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" has been added to offering. The Japan Baby Care Products Market was valued at USD 8.56 Billion in 2024 and is expected to reach USD 12.06 Billion by 2030, rising at a CAGR of 5.88%. Despite a declining birth rate, the market continues to expand, driven by higher per-child spending and a shift toward sustainable and health-conscious baby products. Japanese consumers increasingly favor organic and natural items in segments such as lotions, shampoos, wipes, and diapers, reflecting heightened concerns around product safety and skin sensitivity. The demand for high-quality, safe baby care items is further supported by the country's strong appreciation for artisanal and culturally inspired ingredients. Meanwhile, the rapid expansion of e-commerce and omnichannel retail is increasing accessibility to a wider variety of baby products. In line with this, Japan's eCommerce sector is forecast to generate revenue of USD 190.53 billion by 2025. These trends underscore the market's resilience and evolving consumer preferences, shaping its trajectory through the next decade. Key Market Drivers: Government Initiative & Policies Supporting the Food Sector The Japanese government has rolled out strategic initiatives aimed at improving nutrition among families, particularly focusing on pregnant women and young children. A core part of this effort is the Measures for Achievement of Decarbonization and Resilience with Innovation (MeaDRI), targeting zero CO2 emissions in agriculture and food systems by 2050 through sustainable practices and waste reduction. These policies support healthier food systems and reinforce the broader baby care ecosystem. The Tokyo Nutrition for Growth Summit 2021 Action Plan is another key initiative, emphasizing collaborative medical and governmental education campaigns to enhance maternal nutrition and reduce underweight pregnancies. These policies, combined with measures against childhood obesity and a stable regulatory environment, are strengthening the outlook for the baby food and baby care product markets. Key Market Challenges: Declining Birth Rate A significant obstacle for Japan's baby care products market is the continued drop in birth rates. As of 2024, Japan recorded approximately 720,000 births-the lowest since records began-reflecting a 5% decline from the previous year. This demographic shift is shrinking the consumer base for baby products, prompting major companies to reconsider domestic operations. For example, Oji Holdings ceased domestic baby diaper production to pivot toward adult incontinence products, reflecting changing market priorities. Japan's aging population, with nearly 30% aged 65 or above, exacerbates the challenge by reducing the workforce and economic productivity. While government incentives for childbirth and childcare support exist, their impact has yet to reverse the downward trend, posing long-term implications for the baby care industry. Key Market Trends: Cultural Preferences for Traditional Ingredients Cultural affinity for traditional, natural ingredients strongly influences consumer preferences in Japan's baby care segment. Parents are increasingly drawn to products incorporating heritage-based, gentle ingredients such as rice bran oil for its moisturizing properties, green tea extract for its soothing benefits, and sakura (cherry blossom) extract for its symbolic and aesthetic appeal. These components not only meet the demand for skin-friendly and safe formulations but also reflect deep-rooted cultural values. As such, manufacturers are embedding these traditional elements into baby care lines to resonate with consumers seeking authenticity and quality. This trend enhances product differentiation and reinforces local identity in a competitive and globalized market. Key Market Players: Oji Holdings Corporation Morinaga Milk Industry Co., Ltd Meiji Holdings CO., Ltd Asahi Group Foods, Ltd Miki Shoko Co., Ltd The Procter & Gamble Company Kimberly-Clark Corporation Kenvue Brands Unicharm Corporation Himalaya Wellness Company Report Scope: In this report, the Japan Baby Care Products Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below: Japan Baby Care Products Market, By Product Type: Skin Care Toiletries Hair Care Food & Beverages Others Japan Baby Care Products Market, By Age Group: 0-12 Months 13-24 Months 24-48 Months Japan Baby Care Products Market, By Sales Channel: Supermarkets/Hypermarkets Specialty Stores Pharmacies/Drug Stores Online Others Japan Baby Care Products Market, By Region: Hokkaido & Tohoku Chubu Chugoku Kyushu Rest of Japan Key Attributes: Report Attribute Details No. of Pages 82 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $8.56 Billion Forecasted Market Value (USD) by 2030 $12.06 Billion Compound Annual Growth Rate 5.8% Regions Covered Japan For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Japanese Baby Care Products Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio


Associated Press
43 minutes ago
- Associated Press
Catheter Precision (VTAK) Reports Key Progress for the LockeT Product
FORT MILL, S.C., June 12, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced that LockeT sales for Q2 2025 are on track to be the highest to date. Second quarter 2025 LockeT sales are already outpacing Q2 2024 sales with a 200% increase. Catheter Precision now has several US hospitals that are on track to issue more than $100,000 in purchase orders each for LockeT by the end of 2025. These hospitals include Montefiore (Bronx, NY), Eisenhower Health (Rancho Mirage, CA), and Overland Park Regional Medical Center (Overland Park, KS). As previously announced, LockeT received the CE Mark enabling sales in Europe. Catheter Precision has secured a new distributor in Italy and anticipates additional distributors in the coming days for Spain, Portugal and the UK and is actively searching for the right partner is other EU countries. David Jenkins, CEO of Catheter Precision said, 'We are excited about the upcoming activities, sales pipeline and expanded use by existing customer to increase revenue generated by LockeT. At this time, there is a live case scheduled on Monday, Juen 16 with a key opinion leader where he will demonstrate LockeT during an Italian symposium, increasing its awareness to the new market. As a company, we continue to focus on improving product awareness, increasing product usage and expanding our footprint into Europe.' About LockeT Catheter Precision's LockeT is a suture retention device intended to assist in wound closure after percutaneous venous punctures. LockeT is a Class 1 device registered with the FDA and has received CE Mark approval. About Catheter Precision Catheter Precision is an innovative U.S.-based medical device company bringing new solutions to market to improve the treatment of cardiac arrhythmias. It is focused on developing groundbreaking technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products. Cautionary Note Regarding Forward-Looking Statements Statements in this press release may contain 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to substantial risk and uncertainties. Forward-looking statements can be identified by words such as 'believe,' 'anticipate,' 'may,' 'might,' 'can,' 'could,' 'continue,' 'depends,' 'expect,' 'expand,' 'forecast,' 'intend,' 'predict,' 'plan,' 'rely,' 'should,' 'will,' 'may,' 'seek,' or the negative of these terms and other similar expressions, although not all forward-looking statements contain these words. These forward-looking statements include, but are not limited to, statements regarding product evaluations at the hospital, and that the purchase order indicates that the hospital and its staff see the value and benefits that LockeT can bring and expectations regarding LockeT evaluations in the coming weeks. The Company's expectations and beliefs regarding these matters may not materialize. Actual outcomes and results may differ materially from those contemplated by these forward-looking statements as a result of uncertainties, risks and changes in circumstances, including but not limited to risks and uncertainties included under the caption 'Risk Factors' in the Company's Form 10-K filed with the SEC and available at The forward-looking statements included in this communication are made only as of the date hereof. The Company assumes no obligation and does not intend to update these forward-looking statements, except as required by law. CONTACTS: At the Company David Jenkins 973-691-2000 [email protected] # # #